Distinct inflammatory patterns and nasal bacterial dysbiosis in uncontrolled chronic rhinosinusitis
- PMID: 40234310
- DOI: 10.1007/s00405-025-09376-y
Distinct inflammatory patterns and nasal bacterial dysbiosis in uncontrolled chronic rhinosinusitis
Abstract
Objective: The concept of disease control is increasingly gaining importance in the long-term management of chronic rhinosinusitis (CRS). Eosinophilic inflammation has been identified as a high-risk factor for uncontrolled CRS. Although evidence suggests that dysbacteriosis is involved in the pathogenesis of eosinophilic CRS, its association with disease control has not been explored. We attempt to explore the inflammatory patterns and nasal bacterial dysbiosis among patients with uncontrolled CRS.
Methods: We performed a cross-sectional study of 48 patients with uncontrolled CRS, 44 patients with controlled CRS, and 58 healthy controls. Uncontrolled CRS was defined according to European Position Paper on Rhinosinusitis and Nasal Polyps 2020. The nasal mucus and peripheral venous blood were collected for inflammatory endotype analysis. The bacterial microbiota of the swab from the middle meatus was profiled by sequencing the V3-V4 region of the 16S rRNA gene.
Results: Uncontrolled CRS showed significantly higher levels of mucus eosinophil-derived neurotoxin (EDN) (P < 0.001), blood eosinophil counts (P = 0.002), blood basophil counts (P = 0.020), and blood lymphocyte counts (P = 0.033) than patients with controlled CRS. The nasal mucus EDN level was the best predictor of uncontrolled CRS, with the highest area under the receiver operating characteristic curve (AUC) of 0.798 (95% confidence interval [CI] = 0.692-0.904) compared to other inflammatory parameters. Patients with uncontrolled CRS exhibited a significant increase in the abundance of seven genera. Except for Ralstonia and Acinetobacter, the other five genera had a mean relative abundance < 1%, including Klebsiella and Pseudomonas. By random forest analysis, we established a model for the nasal microbiome with an AUC of 0.949 (95% CI = 0.903-0.996). Upon incorporating peripheral eosinophil and basophil counts into the model, we found an enhancement in diagnostic capability, with an AUC of 0.974 (95% CI = 0.944-1.000).
Conclusions: Patients with uncontrolled CRS have distinct local and systematic inflammatory patterns and bacterial dysbiosis compared to both controlled CRS and healthy controls, which sheds light on the pathogenesis of uncontrolled status in CRS.
Keywords: Chronic rhinosinusitis; Disease control; Inflammation; Nasal microbiome; Uncontrolled status.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no relevant conflicts of interest. Research involving human participants and/or animals: This study was approved by the Ethics Committee (number 2020100X). Informed consent: Written informed consent was obtained from all the patients.
Similar articles
-
Association of mucus eosinophil-derived neurotoxin levels with disease control status in patients with chronic rhinosinusitis.Eur Arch Otorhinolaryngol. 2024 Aug;281(8):4191-4199. doi: 10.1007/s00405-024-08695-w. Epub 2024 May 3. Eur Arch Otorhinolaryngol. 2024. PMID: 38700538
-
Rare constituents of the nasal microbiome contribute to the acute exacerbation of chronic rhinosinusitis.Inflamm Res. 2025 Jan 11;74(1):14. doi: 10.1007/s00011-025-01995-9. Inflamm Res. 2025. PMID: 39797944
-
Biodiversity of the Bacterial and Fungal Microbiome and Associated Inflammatory Cytokine Profile in Chronic Rhinosinusitis.Int Forum Allergy Rhinol. 2025 May;15(5):502-512. doi: 10.1002/alr.23519. Epub 2025 Jan 8. Int Forum Allergy Rhinol. 2025. PMID: 39776217 Free PMC article.
-
The Microbiome and Chronic Rhinosinusitis.Immunol Allergy Clin North Am. 2020 May;40(2):251-263. doi: 10.1016/j.iac.2019.12.009. Epub 2020 Jan 16. Immunol Allergy Clin North Am. 2020. PMID: 32278449 Free PMC article. Review.
-
A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS).Clin Exp Allergy. 2016 Jan;46(1):21-41. doi: 10.1111/cea.12666. Clin Exp Allergy. 2016. PMID: 26510171 Free PMC article. Review.
References
-
- Sung-Dong K, Kyu-Sup C (2023) Treatment strategy of uncontrolled chronic rhinosinusitis with nasal polyps: a review of recent evidence. Int J Mol Sci 24(5):5015. https://doi.org/10.3390/ijms24055015 - DOI
-
- Gao WX, Ou CQ, Fang SB et al (2016) Occupational and environmental risk factors for chronic rhinosinusitis in China: a multicentre cross-sectional study. Respir Res 17(1):54. https://doi.org/10.1186/s12931-016-0366-z - DOI - PubMed - PMC
-
- Lourijsen ES, Fokkens WJ, Reitsma S (2020) Direct and indirect costs of adult patients with chronic rhinosinusitis with nasal polyps. Rhinology 58(3):213–217. https://doi.org/10.4193/Rhin19.468 - DOI - PubMed
-
- Fokkens WJ, Lund VJ, Hopkins C et al (2020) European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology 58(Suppl29):1–464. https://doi.org/10.4193/Rhin20.600 - DOI - PubMed
-
- Baguley C, Brownlow A, Yeung K, Pratt E, Sacks R, Harvey R (2014) The fate of chronic rhinosinusitis sufferers after maximal medical therapy. Int Forum Allergy Rhinol 4(7):525–532. https://doi.org/10.1002/alr.21315 - DOI - PubMed
MeSH terms
Grants and funding
- 82000954/Natural Science Foundation of China
- Z201100006820086/Beijing Science and Technology Nova Program
- QML20190617/Beijing Hospitals Authority Youth Program
- XMLX202136/Beijing Hospitals Authority Clinical Medicine Development of Special Funding
- BYSYZD2023029/Key clinical projects of Peking University Third Hospital
LinkOut - more resources
Full Text Sources
Medical